Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
BTK C481S
i
Other names:
BTK, Bruton Tyrosine Kinase, Bruton Agammaglobulinemia Tyrosine Kinase, Tyrosine-Protein Kinase BTK, Bruton'S Tyrosine Kinase, B-Cell Progenitor Kinase, AGMX1, ATK, BPK, Tyrosine-Protein Kinase BTK Isoform (Lacking Exon 13 To 17), Dominant-Negative Kinase-Deficient Brutons Tyrosine Kinase, Tyrosine-Protein Kinase BTK Isoform (Lacking Exon 14), Truncated Bruton Agammaglobulinemia Tyrosine Kinase, Agammaglobulinaemia Tyrosine Kinase, Agammaglobulinemia Tyrosine Kinase, PSCTK1, IGHD3, IMD1, XLA, AT
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
695
Related biomarkers:
Expression
Mutation
‹
BTK mutation (3)
BTK C481 (2)
BTK C481R (2)
BTK C481R + BTK L528W (1)
BTK C481S + BTK R665W + BTK L845F + BTK S707Y (1)
BTK C481S + PLCG2 D1140G (1)
BTK C481S + PLCG2 D1140N (1)
BTK C481S + PLCG2 L845F (1)
BTK C481Y (1)
BTK L528W + BTK C481 (1)
BTK R665W (1)
BTK T474I (1)
BTK C481S + MYD88 mutation (0)
BTK L845F (0)
BTK S707Y (0)
BTK mutation (3)
BTK C481 (2)
BTK C481R (2)
BTK C481R + BTK L528W (1)
BTK C481S + BTK R665W + BTK L845F + BTK S707Y (1)
BTK C481S + PLCG2 D1140G (1)
BTK C481S + PLCG2 D1140N (1)
BTK C481S + PLCG2 L845F (1)
BTK C481Y (1)
BTK L528W + BTK C481 (1)
BTK R665W (1)
BTK T474I (1)
BTK C481S + MYD88 mutation (0)
BTK L845F (0)
BTK S707Y (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
BTK C481S
Chronic Lymphocytic Leukemia
BTK C481S
Chronic Lymphocytic Leukemia
acalabrutinib
Resistant: A2 - Guideline
acalabrutinib
Resistant
:
A2
acalabrutinib
Resistant: A2 - Guideline
acalabrutinib
Resistant
:
A2
BTK C481S
Chronic Lymphocytic Leukemia
BTK C481S
Chronic Lymphocytic Leukemia
pirtobrutinib
Sensitive: C3 – Early Trials
pirtobrutinib
Sensitive
:
C3
pirtobrutinib
Sensitive: C3 – Early Trials
pirtobrutinib
Sensitive
:
C3
BTK C481S
Chronic Lymphocytic Leukemia
BTK C481S
Chronic Lymphocytic Leukemia
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
BTK C481S
Mantle Cell Lymphoma
BTK C481S
Mantle Cell Lymphoma
TG-1701
Sensitive: D – Preclinical
TG-1701
Sensitive
:
D
TG-1701
Sensitive: D – Preclinical
TG-1701
Sensitive
:
D
BTK C481S
Chronic Lymphocytic Leukemia
BTK C481S
Chronic Lymphocytic Leukemia
GS-9973
Sensitive: D – Preclinical
GS-9973
Sensitive
:
D
GS-9973
Sensitive: D – Preclinical
GS-9973
Sensitive
:
D
BTK C481S
Mantle Cell Lymphoma
BTK C481S
Mantle Cell Lymphoma
ibrutinib
Resistant: D – Preclinical
ibrutinib
Resistant
:
D
ibrutinib
Resistant: D – Preclinical
ibrutinib
Resistant
:
D
BTK C481S
Mantle Cell Lymphoma
BTK C481S
Mantle Cell Lymphoma
SRX3262
Sensitive: D – Preclinical
SRX3262
Sensitive
:
D
SRX3262
Sensitive: D – Preclinical
SRX3262
Sensitive
:
D
BTK C481S
Chronic Lymphocytic Leukemia
BTK C481S
Chronic Lymphocytic Leukemia
SNS-062
Sensitive: D – Preclinical
SNS-062
Sensitive
:
D
SNS-062
Sensitive: D – Preclinical
SNS-062
Sensitive
:
D
BTK C481S
Diffuse Large B Cell Lymphoma
BTK C481S
Diffuse Large B Cell Lymphoma
ABBV-101
Sensitive: D – Preclinical
ABBV-101
Sensitive
:
D
ABBV-101
Sensitive: D – Preclinical
ABBV-101
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.